Drug Trial Radar · NCT03901092
A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation
Last checked: Nov 20, 2026Latest source record: Sep 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
242
Actual
Start
Mar 26, 2019
Primary completion
Apr 26, 2019
Study completion Apr 26, 2019
Sponsor
- Lead sponsor
- Avid RadiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Apr 3, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the performance of physician readers trained to read flortaucipir-PET (positron emission tomography) scans.
Conditions
- Alzheimer Disease
Interventions
flortaucipir F 18Drug
No study drug will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Objective 1 Analysis 1: Diagnostic Performance of Individual Readers (NFT Score)Time frame: baseline scan
- Primary Objective 1 Analysis 2: Diagnostic Performance of Individual Readers (NIA-AA Autopsy Diagnosis)Time frame: baseline scan
- Primary Objective 2: Inter-reader Reliability of Reader Interpretation of Flortaucipir-PET ImagingTime frame: baseline scan
Locations
1 site in 1 country. Site status is shown where the registry gives one.
American College of Radiology
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.